The "Report on China's Medical Device Market Entry and Business Environment" was first released

The "Report on China's Medical Device Market Entry and Business Environment" (hereinafter referred to as the "Report") was recently released at the 5th China International Import Expo, which is China's first report that systematically displays the macro environment of the medical market and the landing policies of various provinces and cities, providing an important reference and direction
for overseas innovative medical enterprises to understand China's major policy opportunities and specific landing paths.

 

On the one hand, the "China Medical Device Market Entry and Business Environment Report" depicts China's economy and medical device market environment from a macro perspective, and shows the attractiveness of the Chinese market to foreign-funded medical device enterprises around the world; On the other hand, by sorting out the relevant policies of key provinces and cities in terms of market access, clinical application, reimbursement treatment, and attracting foreign investment of innovative medical devices, combined with the successful cases of overseas enterprises in China, we can help overseas enterprises understand the major policy opportunities and specific landing paths in the Chinese market, and inspire more global medical technology innovation projects to take root in China
.

 

Since the beginning of the 21st century, China's medical device market as a whole has entered a stage of rapid growth, with a compound annual growth rate of more than 10%, leading the global medical device market
in terms of growth.
In 2021, China's medical device market reached US$56 billion, making it the second largest market
in the world.
It is expected that in the next 10 years, China's medical device market will maintain double-digit rapid growth, and the market size is expected to be about 145 billion US dollars in 2030, accounting for 19% of
the global medical device market.

 

The "Report on China's Medical Device Market Entry and Business Environment" released this time is the first time that the medical industry has systematically sorted out and displayed policies to attract overseas innovative technologies.
It is an important step in supporting the development of innovative medical enterprises in China; It is also in line with the spirit of the "Several Policies and Measures on Promoting the Expansion of Foreign Investment with a Focus on Manufacturing", Stabilizing Stock and Improving Quality with a Focus on Manufacturing Recently, and is committed to promoting the high-quality development
of foreign investment in China.

 

The Innovation Incubation Zone (Medical Field) of the Expo was first established in 2021, and this year the special committee has strengthened the docking of incubation guidance and investment resources, and is committed to providing efficient and useful all-round ecological support for innovative medical technology enterprises
.
On the one hand, the committee led the executives of more than 40 global industry leaders to form a "mentor group", including Bidt Medical, Medtronic, Johnson & Johnson, GE Healthcare, Siemens Healthineers, Abbott and so on
.
Their profound understanding of the global innovation ecology and the resources of China's medical market accumulated over the years were taught to the participating innovative enterprises, and multi-dimensional discussions and guidance
were carried out.
On the other hand, in the recruitment stage of the innovation incubation zone, dozens of domestic leading medical investment institutions such as DeDaF Capital, Hillhouse Capital, CITIC Capital, Haoyue Capital, Warburg Pincus, as well as professional service companies in the medical technology industry such as Wanjiang Innovation Medical, Shanghai Yongzheng, Beijing Qiudi Coco and other medical technology industry were introduced to provide guidance
for innovative enterprises from the perspective of professional investment.

 

It is reported that the Medical Device Committee will continue to enhance its value and influence from four major directions in the future, and build the medical innovation incubation zone into a medical innovation platform and fertile soil
for incubation with global influence.
Specifically, it will further enhance the international influence of the Medical Innovation Incubation Zone; Further expand the medical specialties covered by the innovation project and upgrade the technical specifications; Effectively run the path of innovative projects landing in China and form a replicable model; and grafting resources from more dimensions to actively promote "empowering and co-creating and realizing the dream of China"
.
(End)